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演　題：Functional dissection of nuclear receptor sig-
nalling in mice by cell-type specific temporally-






抄　録：Retinoids, the active metabolites of Vitamin A,
regulate complex gene networks involved in vertebrate
morphogenesis, organogenesis, growth, cellular differen-
tiation and homeostasis.  The actions of retinoids are
mediated by the retinoic acid receptors (RARα, β and γ)
and the retinoid X receptors (RXRα, β and γ) that belong
to the nuclear receptor (NR) superfamily.  RXRs not only
heterodimerize with RARs, but also with other members
of the nuclear receptor superfamily, e.g. the Vitamin D
receptor (VDR), the Thyroid hormone receptors (TRs)
and the Peroxisome Proliferator activated receptors
(PPARs).  This complexity in “hormonal” signalling
through transduction by NRs, the functional redundancies
within receptor isotypes, as well as in utero or post-natal
lethality of germline mutation of certain NRs, preclude a
simple genetic analysis of the in vivo function of NRs
using conventional gene knock-out approaches.
To generate somatic mutations in a defined gene, at a
given life time of an animal, and in a specific cell type,
we developed a new genetic tool based on the bacterio-
phage P1-Cre/lox system.  A conditional ligand-inducible
Cre recombinase, Cre-ERT2, has been generated by fusing
Cre with a mutated ligand binding domain of the human
oestrogen receptor that binds the synthetic ligand tamox-
ifen, but not estradiol.  Upon tamoxifen administration to
transgenic mice cell-specifically expressing Cre-ERT2, the
Cre activity is induced and DNA segments flanked by
two loxP sites (“floxed”) are efficiently and selectively
excised in Cre expressing cells.  The use of such a strate-
gy allowed us to study RXRs and some of their het-
erodimeric partners in various tissues, including epider-
mal keratinocytes, hepatocytes and adipocytes.  Some




演　題：Research & Development of Innovative
Therapeutics by Using In Vitro Models
演　者：中華人民共和国上海　 旦（Fudan）大学薬学部
薬理学
教授　Dr. Zhuohan HU, Ph.D.
座　長：がん研究所分子病理病態学部門
教授　三高　俊広
抄　録：The presentation will be focused on application
of advanced in vitro technologies into discovery and
development of innovative therapeutics in China.  The
presentation will detail ethical and legal statuses on
preparation of human tissue based in vitro models in
China, and analyze challenges and difficulties Chinese
pharmacologists faced, and propose solutions and strate-
gies for further application of human tissue based in vitro












































































教授　David C. Spray, Ph.D.
座　長：病理学第二講座
教授　澤田　典均
抄　録：Gap junctions, once thought to be mere tunnels
connecting adjacent cells, are now recognized as macro-
molecular signaling complexes (the “Nexus”), with
binding affinities among the components being modified
by such factors as phosphorylation state, thereby chang-
ing distribution and function of the complex within the
cell.  Moreover, our microarray studies of connexin null
mice indicate that altered expression of connexin genes
results in downstream and parallel ripplesthroughout the
transcriptome that contribute to the total phenotypic
change.  In this presentation, we will discuss connexin-
protein interactions, the nature of the transcriptomic inter-
linkages of connexin and other genes and proposed mech-
anisms for such linkages, and consequences in pathologi-
cal situations in which connexin expression is altered.

